Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Retterspitz Innerlich is a herbal-based medical device developed and manufactured by the German company Retterspitz GmbH & Co. KG. It has been commercially available since 1920 and is indicated for the treatment of acute and chronic gastrointestinal conditions, including heartburn, dyspepsia, bloating, and feelings of fullness. The product is a milky, nonsterile, colloidal suspension that operates through a physicochemical buffering mechanism to balance stomach acid levels (addressing both hypo- and hyperchlorhydria) rather than interacting with specific molecular targets. Its complex formulation includes citric acid monohydrate, tartaric acid, aluminum potassium sulfate (alum), denatured hen's egg protein, and essential oils such as thyme, orange, and lemon oil. It is free from sugar, gluten, and lactose.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Retterspitz Innerlich.